|
AU2008240667A1
|
|
Medicaments and methods to treat autoimmune disease and cancer
|
|
US2005250691A1
|
|
Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes
|
|
US2005209138A1
|
|
Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes
|
|
WO9927956A1
|
|
Tolerance inducing combination of at least two endogenous antigens for treatment of sms, sle, iddm, etc.
|
|
WO9849279A1
|
|
Use of a zwitterionic detergent/surfactant for purifying glutamic acid decarboxylase (gad) and a composition containing gad
|
|
US6093396A
|
|
Modified glutamic acid decarboxylase (GAD)
|
|
EP0852619A1
|
|
A modified glutamic acid decarboxylase (gad)
|
